Literature DB >> 10364122

Clinical evidence: atopic eczema.

C Charman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10364122      PMCID： PMC1115970          DOI： 10.1136/bmj.318.7198.1600

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  24 in total

Review 1.  Is the prevalence of atopic dermatitis increasing?

Authors:  H C Williams
Journal:  Clin Exp Dermatol       Date:  1992-11       Impact factor: 3.470

2.  Egg and milk exclusion diets in atopic eczema.

Authors:  V S Neild; R A Marsden; J A Bailes; J M Bland
Journal:  Br J Dermatol       Date:  1986-01       Impact factor: 9.302

3.  In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new.

Authors:  M J Kerscher; H Hart; H C Korting; D Stalleicken
Journal:  Int J Clin Pharmacol Ther       Date:  1995-04       Impact factor: 1.366

4.  Adrenal function following topical steroid treatment in children with atopic dermatitis.

Authors:  L Patel; P E Clayton; G M Addison; D A Price; T J David
Journal:  Br J Dermatol       Date:  1995-06       Impact factor: 9.302

5.  Food hypersensitivity and atopic dermatitis: evaluation of 113 patients.

Authors:  H A Sampson; C C McCaskill
Journal:  J Pediatr       Date:  1985-11       Impact factor: 4.406

6.  Topical glucocorticoids of the non-fluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasound.

Authors:  M J Kerscher; H C Korting
Journal:  Acta Derm Venereol       Date:  1992       Impact factor: 4.437

7.  The prevalence of childhood atopic eczema in a general population.

Authors:  J Kay; D J Gawkrodger; M J Mortimer; A G Jaron
Journal:  J Am Acad Dermatol       Date:  1994-01       Impact factor: 11.527

8.  Fusidic acid plus betamethasone in infected or potentially infected eczema.

Authors:  N Hjorth; H Schmidt; K Thomsen
Journal:  Pharmatherapeutica       Date:  1985

9.  The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation.

Authors:  H C Williams; P G Burney; A C Pembroke; R J Hay
Journal:  Br J Dermatol       Date:  1994-09       Impact factor: 9.302

10.  A double-blind controlled crossover trial of an antigen-avoidance diet in atopic eczema.

Authors:  D J Atherton; M Sewell; J F Soothill; R S Wells; C E Chilvers
Journal:  Lancet       Date:  1978-02-25       Impact factor: 79.321
View more
  4 in total

1.  Evidence based medicine.

Authors:  T Eden
Journal:  Arch Dis Child       Date:  2000-04       Impact factor: 3.791

Review 2.  Recent advances in treatment strategies for atopic dermatitis.

Authors:  Thomas Christian Roos; Stefan Geuer; Sabine Roos; Harald Brost
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Fusidic acid resistance in Staphylococcus aureus.

Authors:  D Dobie; J Gray
Journal:  Arch Dis Child       Date:  2004-01       Impact factor: 3.791

4.  Formulation and clinical evaluation of silymarin pluronic-lecithin organogels for treatment of atopic dermatitis.

Authors:  Fatma M Mady; Hanaa Essa; Tarek El-Ammawi; Hamdy Abdelkader; Amal K Hussein
Journal:  Drug Des Devel Ther       Date:  2016-03-10       Impact factor: 4.162
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.